CRISM Therapeutics Corporation
CRTX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £1,282 | £3,439 | £2,896 | £4,933 |
| Short-Term Investments | £0 | £945 | £0 | £0 |
| Receivables | £0 | £15 | £0 | £18 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £408 | £387 | £52 | £63 |
| Total Curr. Assets | £1,690 | £4,786 | £2,948 | £5,014 |
| Property Plant & Equip (Net) | £52 | £0 | £0 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £74 | £59 | £0 | £0 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £87 | £20,945 | £18,049 |
| Total NC Assets | £126 | £145 | £20,945 | £18,049 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £1,816 | £4,786 | £23,893 | £23,063 |
| Liabilities | – | – | – | – |
| Payables | £29 | £471 | £131 | £101 |
| Short-Term Debt | £0 | £501 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £312 | -£310 | £488 | £863 |
| Total Curr. Liab. | £341 | £662 | £619 | £964 |
| LT Debt | £0 | £388 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £146 | £0 |
| Total NC Liab. | £0 | £388 | £146 | £117 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £341 | £662 | £766 | £832 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £66,225 | £80,794 | £67,166 | £80,449 |
| Retained Earnings | -£1,208 | -£80,948 | -£33,693 | -£37,516 |
| AOCI | £0 | £0 | -£13,902 | -£17,100 |
| Other Equity | -£63,542 | £4,278 | £3,556 | £4,278 |
| Total Equity | £1,475 | £4,124 | £23,127 | £30,111 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £1,816 | £4,786 | £23,893 | £23,063 |
| Net Debt | -£1,282 | -£2,550 | -£2,896 | -£4,933 |